Iontophoretic drug delivery system: A review

Technology and Health Care

Volumn 15, Issue 4, 2007, Pages 237-245

  Semalty, Ajay ^a,d   Semalty, Mona ^a   Singh, Ranjit ^b   Saraf, Shailendra K ^b   Saraf, Shubhini ^c  

^a HNBG University   (India)

^b NIEC   (India)

^c BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^d H N B GARHWAL UNIVERSITY   (India)

Author keywords

Iontophoresis; Iontophoretic systems; Transdermal drug delivery

Indexed keywords

AMINO ACID DERIVATIVE; ANGIOTENSIN; APOMORPHINE; ATENOLOL; CALCITONIN; DESMOPRESSIN; ENKEPHALIN DERIVATIVE; GELATIN; GONADORELIN; HEPARIN; HIRUDIN; HYDROXOCOBALAMIN; INSULIN; LEUPRORELIN; LIDOCAINE; LITHIUM CHLORIDE; NUCLEOSIDE; NUCLEOTIDE; OXYTOCIN; PEPTIDE; PROCAINAMIDE; PROPRANOLOL; PROSTAGLANDIN E1; PROTEIN; PROTIRELIN; TRIPEPTIDE; UNINDEXED DRUG; VASOPRESSIN; VERAPAMIL; ZIDOVUDINE;

ALLERGY TEST; ANESTHESIA; ANTIVIRAL THERAPY; CANCER THERAPY; CYSTIC FIBROSIS; DENTAL CARIES; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUTION; ELECTRIC CURRENT; ELECTRODE; HUMAN; HYDROPHOBICITY; HYPERHIDROSIS; INFECTION RISK; IONTOPHORESIS; MICROEMULSION; MOLECULAR SIZE; MUSCLE DISEASE; MYCOSIS; NEURALGIA; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; POWER SUPPLY; PRIORITY JOURNAL; REVIEW; SCLERODERMA; SKIN DISEASE; SKIN PERMEABILITY;

EID: 34547674745     PISSN: 09287329     EISSN: None     Source Type: Journal    
DOI: 10.3233/thc-2007-15402     Document Type: Review

References (66)

1. 1,, Ann Plas Surg 38(5) (1997), 514-521.
2. B. Avitall, J. Hare, G. Zander, C. Bockoff, P. Tchou, M. Jazayeri and M. Akhtar, Iontophoretic Transmyocardial Drug Delivery A Novel Approach to antiarrhythmic drug therapy, Circulation 85(4) (1992), 1582.
3. A.K. Banga and Y.W. Chien, Characterisation of in vitro transdermal iontophoretic delivery of insulin, Drug Dev Ind Pharm 19 (1993), 2069.
4. A.K. Banga and Y.W. Chien, Hydrogel-based iontotherapeutic delivery devices for. transdermal delivery of peptide/protein drugs, Pharm Res 10(5) (1993), 697-702.
5. A.K. Banga and Y.W. Chien, Iontophoretic delivery of drugs: Fundamentals, developments and biomedical applications, J Control Release 7 (1988), 2069-2082.
6. A.K. Banga, M. Katakam and R. Mitra, Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin, Int J Pharm 116 (1995), 211-216.
7. C.R. Behl, S. Kumar, A.W. Malick, S. del Terzo, W.I. Higuchi and R.A. Nash, Iontophoretic durg delivery effects of physicochemical factors on the skin uptake of nonpeptide drugs, J Pharm Sci 78 (1989), 355-360.
8. S. Bhaskaran and N.S. Harsha, Effect of permeation enhancer and iontophoresis on permeation of atenolol from transdermal gels, Indian J Pharm Sci 6 (2000), 424-429.
9. H.E. Bodde, J.C. Verhoef and M. Ponec, Transdermal peptide delivery, Biochem Soc Trans 17 (1989), 943-945.
10. R.R. Burnette and D. Marrero, Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone, J Pharm Sci 75 (1986), 738-742.
11. G. Chandrashaker, R. Bhat, M.K. Singh and N. Udupa, Optimization of parameters for transdermal permeation of insulin, Indian J Pharm Sci 56 (1994), 205.
12. Y.W. Chien and A.K. Banga, Iontophoretic (transdermal) delivery of drugs: overview of historical development, J Pharm Sci 78 (1989), 353-354.
13. Y.W. Chien and A.K. Banga, Iontophoretic delivery of drugs: fundamentals, developments, and biomedical applications, J Control Release 7 (1988), 1-24.
14. Y.W. Chien, P. Lelawongs, O. Siddiqui, Y. Sun and W.M. Shim, Facilitated transdermal delivery of therapeutic peptide and. proteins by iontophoretic delivery devices, J Control. Release 13 (1990), 263-278.
15. H.K. Choi, G.L. Flynn and G.L. Amidon, Transdermal delivery of bioactive peptides: the effect of n-decylmethyl sulfoxide on Enkephalin metabolism and transport, Pharm Res 7 (1990), 1099-1106.
16. M. Clemessy, G. Couarraze, B. Bevan and F. Puisieux, Mechanisms involved in iontophoretic transport of angiotensins, Pharm Res 12 (1995), 998.
17. M. Clemessy, G. Couarraze, B. Bevan and F. Puisieux, Preservation of skin permeability during in vitro iontophoretic skin experiments, Int J Pharm 101 (1994), 219-226.
18. C. Cullander and R.H. Guy, Transdermal delivery of peptides and proteins, Adv Drug Deliv Rev 8 (1992), 291-329.
19. A. Fernandez-Ortiz, B. J. Meyer, A. Mailhac, E. Falk, L. Badimon, J.T. Fallon, V. Fuster, J.H. Chesebro and J.J. Badimon, A new approach for local intravascular drug delivery. Iontophoretic balloon, Circulation 89(4) (1994), 1518.
20. L.P. Gangarosa, Iontophoresis in dental practice, Quintessence Punlishing Co. Inc, Chicago, 1983, 40-52.
21. P.G. Green, A. Kim, G. Rao and R.H. Guy, Convective solvent flow across the skin during iontophoresis, Pharm Res 10 (1993), 1315-1320.
22. P.G. Green, R.S. Hinz, C. Cullander, G. Yamane and R.H. Guy, Iontophoretic delivery of a series of tripeptides across the skin in vitro, Pharm Res 8 (1991), 1113-1124.
23. A. Greg Fischer, M. Thomas Parkinson and A. Margaret Szlek, OcuPhor - The Future of Ocular Drug Delivery, Drug Deliv Tech 1 (2004), 8.
24. M.C. Heit, A. McFarland, R. Bock and J.E. Riviere, Transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH): Effect of repeated administration, Pharm Res 11 (1994), 1000-1009.
25. M.C. Heit, P.L. Williams, F.L. Jayes, S.K. Chang and J.E. Riviere, Isoelectric focussing and capillary zone electrophoretic studies using luteinizing hormone releasing hormone (LHRH) and its analogues, J Pharm Sci 82 (1993), 240-247.
26. J. Hirvonen, Iontophoretic delivery: Progress to date and therapeutic potential, Am J Drug Delivery 3 (2005), 67-81.
27. J.P. Howard, T.R. Drake and D.L. Jr Kellogg, Effects of alternating current iontophoresis on drug delivery, Arch Phys Med Rehabil 76(5) (1995), 463-463.
28. N. Kannikannan, J. Singh and P. Ramarao, Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue, J Control Release 59 (1999), 99-105.
29. S. Kantaria, G.D. Rees and M.J. Lawrence, Formulation of electrically conducting micro- emulsion-based organogels and application in iontophoretic transdermal drug delivery, J Control Release 60 (1999), 355-365.
30. B. Kari, Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin, Diabetes 35 (1986), 217-221.
31. R.K. Khar and A. Nanda, Iontophoretic Drug Delivery, in: Controlled and Novel Drug Delivery System, N.K. Jain, ed., C.B.S. Publishers and Distributors, New Delhi, 2005, pp. 191-198.
32. G.P. Kushla and J.L. Zatz, Influence of pH on lidocaine penetration through human and hairless mouse skin in vitro, Int J Pharm 71 (1991), 167-173.
33. L. Langkjoer, Insulin delivery by Iontophoresis, Proc Int Sym Cont Rel Bioact Mater 21 (1994), 321.
34. P. Lelawongs, Y.W. Chien, O. Siddiqui, W.-M Shi and J.-C. Liu, Transdermal iontophoretic delivery of arginine-vasopressin (1): Physicochemical consideration, Int J Pharm 56 (1989), 13-22.
35. P. Lelawongs, Y.W. Chien, O. Siddiqui, W.M. Shi and J.-C. Liu, Transdermal iontophoretic delivery of argininevasopressin (2): In vitro and in vivo studies, Int J Pharm 61 (1990), 179-188.
36. J. Leonardo, Iontophresis; An Alternative Drug Delivery- Iontophoresis Balloon, Circulation 89(4) (1994), 1518-1522.
37. S. Matthew, Hastings, S. Kevin Li, David J. Miller, Paul S. Bernstein and Daniel Mufson, Visulex? Advancing Iontophoresis for Effective Noninvasive Back-of-the-Eye Therapeutics, Drug Deliv Tech 4 (2004), 1-3.
38. B.R. Meyer, H.L. Katzeff, J.C. Eschbach, J. Trimmer, S.B. Zacharias and S. Rosen, Trans-. dermal delivery of human insulin to albino rabbits using. electrical current, Am J Med Sci 297 (1989), 321-325.
39. B.R. Meyer, W. Kreis, J. Eschbach, V. O'Mara, S. Rosen and D. Sibalis, Iontophoresis of a model peptide across human. skin in vitro, Clin Pharmacol Ther 48 (1990), 340-345.
40. B.R. Meyer, W. Kreis, J. Eschbach, V. O'Mara, S. Rosen and D. Sibalis, Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers, Clin Pharmacol Ther 44 (1988), 438-444.
41. A.S. Michaeels, S.K. Chandrasekaran and J.E. Shaw, Mechanism of passive transdermal transport, AlChE J 21 (1975), 985-986.
42. L.L. Miller, C.J. Kolaskie, G.A. Smith and J. Rivier, Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogs, J Pharm Sci 79 (1990), 490-498.
43. J.F. Mitchel, M.A. Azrin, D.B. Fram, M.K. Hong, S.C. Wong, J.J. Barry, L.M. Bow, T.M. Curley, F.J. Kiernan and D.D. Waters, Localized delivery of heparin to angio-. plasty sites with iontophoresis, Cathet Cardiovose Diagn 41(3) (1997), 315.
44. M. Nakakura, M Terajima, Y. Kato, E Hayakawa, K. Ito and T. Kuroda, Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally, J Drug Targeting 2 (1995), 487-492.
45. M.E. Peter, T. Jui-Chen and K.M. Gopinathan, Skin barrier and percutaneous drug delivery, in: Dermatology, J.L. Bolognia, J.L. Jorrizo, R.P. Rapini, eds, London: Mosby; 2003, pp. 1969-1978.
46. J.B. Phipps, R.V. Padnabhan and G.A. Lattin, Iontophoretic delivery of mode1 inorganic and drug ions, J Pharm Sci 78 (1989), 365-369.
47. J.E. Riviere, N.A. Monteiro-Riviere, R.A. Rogers, D. Bommannan, J.A. Tamada and R.O. Potts, Pulsatile transdermal delivery of LHRH, J Control Release 36 (1995), 229-237.
48. H.B. Sage, Iontophoresis, in: Percutaneous Penetration Enhancers, E.W. Smith and H.I. Maibach, eds, CRC Press, Boca Raton, FL, 1995, pp. 351-368.
49. H.B. Sage, Iontophoretic drug delivery, in: Encyclopedia of Pharmaceutical Technology, J. Swarbrick and J.C. Boylan, eds, Marcel Dekker, New York, (Vol. 8), pp. 217-221.
50. T.S. Sahota, R.J. Latham, R.G. Linford and P.M. Taylor, In vitro iontophoretic release of lithium chloride and lidocaine, Drug Dev Ind Pharm 26(10) (2000), 1039-1044.
51. P. Santi and R.H. Guy, Reverse Iontophoresis - Parameters Determining Electroosmotic flow: I. pH and ionic strength, J Control Release 38 (1996), 159-165.
52. P.P. Sarpotdar, Iontophoresis, Cosmetics and Toiletries 106 (1991), 94-98.
53. V. Shrinivasan, A.J. Hoogstraate, S.M. Simms and W.I. Higuchi, Iontophoretic enhancement of peptides: behavior of leuprolide versus model permeants, J Control Release 31 (1994), 41-47.
54. V. Shrinivasan, S. Muh, W.I. Higuchi and C.R. Behl, Iontophoresis of polypeptides: Effect of ethanol pretreatment of human skin, J Pharm Sci 79 (1990), 885-887.
55. V. Shrinivasan, W.I. Higuchi, S.M. Sims, A.H. Ghanem and C.R. Behl, Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery, J Pharm Sci 78 (1989), 370-382.
56. O. Siddiqui and Y.W. Chien, Non parenterals administration of peptides and protein drugs, Crit Rev Ther Drug Carrier Sys 3 (1987), 195-221.
57. O. Siddiqui, Y. Sun, J.C. Liu and Y.W. Chien, Facilitated transdermal transport of insulin, J Pharm Sci 76 (1987), 341-345.
58. C.R. Srinivas and R. Rai, Iontophoresis in dermatology, Indian J Dermatol Venereol Leprol 71 (2005), 236-241.
59. D.F. Stamatialis, N. Stafie and M. Wessling, Passive and iontophoretic controlled delivery of salmon calcitonin (sCT) through artificial membranes, Curr Drug Deliv 1 (2004), 137.
60. R.L. Stephan, T.J. Petelenz and S.C. Jacobsen, Potential novel methods for insulin administration: I. Iontophoresis, Biomed Biochem Acta 43 (1984), 553-558.
61. J.A. Tamada, N.J.V. Bomannon and R.O. Potts, Measurement of glucose in diabetic subjects using noninvasive transdermal extraction, Nature Med 11 (1995), 1198-1201.
62. S. Thysman, C. Hauchard and V. Prrat, Human Calcitonin delivery. in rats by iontophoresis, J Pharm Pharmacol 46(9) (1994), 725-730.
63. Y.H. Tu and L.V. Allen, In vitro iontophoretic studies using a synthetic membrane, J Pharm Sci 78 (1989), 211-221.
64. R. Van der Geest, F. Hueber, F.C. Szoka and R.H. Guy, Iontophoresis of Bases, Nucleosides and Nucleotides, Pharm Res 13 (1996), 551-557.
65. L.L. Wearley, K. Tojo and Y.W. Chien, Iontophoresis facilitated transdermal delivery of verapamil, J Control Rel 8(3) (1989), 237-242.
66. C.A. Zakzewski, J. Wasilewski, P. Cawley and W. Ford, Transdermal delivery of regular insulin to chronic diabetic rats: effect of skin preparation and electrical enhancement, J Control Release 50 (1998), 267-272.